CSPC Innovation Pharmaceutical Co Ltd Class A Strategic Asset Allocation Index
CSPC Innovation Pharmaceutical Co Ltd Class A strategic asset allocation index. CSPC Innovation Pharmaceutical Co Ltd Class A (300765) has a Strategic Asset Allocation Index of 22.3% as of June 2023. Strategic assets (PP&E of CN¥1.06 Billion plus long-term investments of CN¥-) total CN¥1.06 Billion, measured against net assets of CN¥4.74 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See CSPC Innovation Pharmaceutical Co Ltd Cl balance sheet quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of CSPC Innovation Pharmaceutical Co Ltd Class A (2016–2022)
Strategic asset allocation index of CSPC Innovation Pharmaceutical Co Ltd Class A from 2016 to 2022. This chart shows how CSPC Innovation Pharmaceutical Co Ltd Class A's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of June 2023, the index stands at 22.3%, representing strategic assets of CN¥1.06 Billion against net assets of CN¥4.74 Billion CNY. Check 300765 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
CSPC Innovation Pharmaceutical Co Ltd Class A Strategic Asset Allocation Index by Year (2016–2022)
CSPC Innovation Pharmaceutical Co Ltd Class A strategic asset allocation index by year from 2016 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for CSPC Innovation Pharmaceutical Co Ltd Class A from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see CSPC Innovation Pharmaceutical Co Ltd Cl stock valuation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 26.7% | CN¥1.05 Billion | CN¥1.05 Billion | CN¥- | CN¥3.94 Billion | ▼ -1.4 pp |
| 2021 | 28.1% | CN¥926.42 Million | CN¥926.42 Million | CN¥- | CN¥3.30 Billion | ▲ +1.0 pp |
| 2020 | 27.1% | CN¥727.49 Million | CN¥727.49 Million | CN¥- | CN¥2.69 Billion | ▼ -1.0 pp |
| 2019 | 28.1% | CN¥678.17 Million | CN¥678.17 Million | CN¥- | CN¥2.42 Billion | ▼ -36.5 pp |
| 2018 | 64.6% | CN¥645.38 Million | CN¥645.38 Million | CN¥- | CN¥999.35 Million | ▼ -11.0 pp |
| 2017 | 75.6% | CN¥579.87 Million | CN¥579.87 Million | CN¥- | CN¥766.93 Million | ▼ -12.0 pp |
| 2016 | 87.6% | CN¥500.86 Million | CN¥500.86 Million | CN¥- | CN¥572.02 Million | — |